Chemicals and Drugs

Palivizumab

A humanized monoclonal antibody and ANTIVIRAL AGENT that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A humanized monoclonal antibody and ANTIVIRAL AGENT that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.

MeSH Record

Classification

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

Synonyms

7 entry terms
  • MEDI 493
  • MEDI-493
  • Monoclonal Antibody MEDI-493
  • Synagis
  • MEDI493
  • Monoclonal Antibody MEDI 493
  • Monoclonal Antibody MEDI493

MeSH Record

Aspects Covered

24 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2016 (1998)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Palivizumab. Medical Subject Headings (MeSH). 2026. Unique ID D000069455. http://id.nlm.nih.gov/mesh/2026/D000069455
  2. Palivizumab. In: Wikipedia. https://en.wikipedia.org/wiki/Palivizumab
  3. Palivizumab. In: Wikidata. https://www.wikidata.org/wiki/Q412765